Next, we undertook tumor re-stimulation experiments to assess whether these formats of IL18 delay the onset of functional exhaustion, indicated by failure to destroy ≥60% of tumor cells within each 72-h re-stimulation cycle. This evidence concerns the gene IL18 and neoplasm.